SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 34 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $247,548 | -43.6% | 279,400 | 0.0% | 0.00% | – |
| Q3 2022 | $439,000 | -31.7% | 279,400 | -12.7% | 0.00% | – |
| Q2 2022 | $643,000 | -13.8% | 320,100 | 0.0% | 0.00% | – |
| Q1 2022 | $746,000 | -49.7% | 320,100 | +0.3% | 0.00% | -100.0% |
| Q4 2021 | $1,484,000 | -53.6% | 319,200 | -23.9% | 0.00% | 0.0% |
| Q3 2021 | $3,198,000 | +1.3% | 419,200 | +28.7% | 0.00% | 0.0% |
| Q2 2021 | $3,157,000 | +17.2% | 325,800 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $2,694,000 | +24.7% | 325,800 | +2.9% | 0.00% | 0.0% |
| Q4 2020 | $2,161,000 | -38.4% | 316,700 | +0.7% | 0.00% | -50.0% |
| Q3 2020 | $3,506,000 | +116.0% | 314,400 | +21.6% | 0.00% | +100.0% |
| Q2 2020 | $1,623,000 | +31.0% | 258,500 | -61.6% | 0.00% | 0.0% |
| Q1 2020 | $1,239,000 | +34.1% | 673,400 | +146.3% | 0.00% | 0.0% |
| Q4 2019 | $924,000 | +149.1% | 273,400 | +57.7% | 0.00% | – |
| Q3 2019 | $371,000 | -10.8% | 173,400 | +11.4% | 0.00% | – |
| Q2 2019 | $416,000 | -40.1% | 155,700 | +6.6% | 0.00% | – |
| Q1 2019 | $694,000 | +140.1% | 146,000 | +21.3% | 0.00% | – |
| Q4 2018 | $289,000 | -21.9% | 120,400 | +43.2% | 0.00% | – |
| Q3 2018 | $370,000 | +9.5% | 84,100 | +79.3% | 0.00% | – |
| Q2 2018 | $338,000 | +120.9% | 46,900 | +20.9% | 0.00% | – |
| Q1 2017 | $153,000 | -19.5% | 38,800 | 0.0% | 0.00% | – |
| Q4 2016 | $190,000 | -31.7% | 38,800 | +8.1% | 0.00% | – |
| Q3 2016 | $278,000 | +57.1% | 35,900 | +13.8% | 0.00% | – |
| Q2 2016 | $177,000 | +32.1% | 31,551 | +26.7% | 0.00% | – |
| Q1 2016 | $134,000 | -48.7% | 24,900 | -17.0% | 0.00% | – |
| Q4 2015 | $261,000 | +19.2% | 30,000 | +14.9% | 0.00% | – |
| Q3 2015 | $219,000 | -23.2% | 26,100 | +61.1% | 0.00% | – |
| Q2 2015 | $285,000 | – | 16,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 2,186,520 | $38,526,000 | 10.61% |
| Cormorant Asset Management, LP | 1,945,334 | $34,277,000 | 4.56% |
| Aisling Capital LLC | 1,703,855 | $30,022,000 | 4.47% |
| Wildcat Capital Management, LLC | 736,012 | $12,968,000 | 4.44% |
| ACUTA CAPITAL PARTNERS, LLC | 212,402 | $3,743,000 | 2.31% |
| Healthcare Value Capital, LLC | 50,000 | $881,000 | 0.92% |
| EAM Investors, LLC | 249,028 | $4,388,000 | 0.51% |
| TFS CAPITAL LLC | 150,812 | $2,657,000 | 0.26% |
| GAGNON SECURITIES LLC | 11,001 | $194,000 | 0.08% |
| Granite Investment Partners, LLC | 43,861 | $772,000 | 0.07% |